Results 1 to 10 of about 20,317 (203)

Development and validation of a nomogram for predicting hyperphosphatemia in non-dialysis patients with chronic kidney disease [PDF]

BMC Nephrology
Background Elevated serum phosphate levels are strongly associated with an increased risk of all-cause mortality in patients with chronic kidney disease (CKD).
Xianhui Zhao, Caiyun Zheng, Qitong Su, Dongli Lu, Shiqin Wu, Zhenghua Jiang, Zhaochun Wu   +6 more
doaj   +2 more sources

Hyperphosphatemia of chronic kidney disease [PDF]

Kidney International, 2008
Observational studies have determined hyperphosphatemia to be a cardiovascular risk factor in chronic kidney disease. Mechanistic studies have elucidated that hyperphosphatemia is a direct stimulus to vascular calcification, which is one cause of morbid cardiovascular events contributing to the excess mortality of chronic kidney disease.
Hruska, Keith A., Mathew, Suresh, Lund, Richard, Qiu, Ping, Pratt, Raymond   +4 more
exaly   +3 more sources

Estrogen inhibits renal Na-Pi Co-transporters and improves klotho deficiency-induced acute heart failure

Redox Biology, 2021
Objective and hypothesis: Klotho is an aging-suppressor gene. Mutation of Klotho gene causes hyperphosphatemia and acute heart failure. However, the relationship of hyperphosphatemia and acute heart failure is unclear.
Kai Chen, Zhongjie Sun
doaj   +1 more source

Understudied Hyperphosphatemia (Chronic Kidney Disease) Treatment Targets and New Biological Approaches

Medicina, 2023
Hyperphosphatemia is a secondary disorder of chronic kidney disease that causes vascular calcifications and bone-mineral disorders. As per the US Centers for Disease Control and Prevention, renal damage requires first-priority medical attention for ...
Ajeeta Anand, Hideki Aoyagi
doaj   +1 more source

Spurious Hyperphosphatemia in a Patient with Multiple Myeloma: A Case Report

Journal of Health Science and Medical Research (JHSMR), 2021
Spurious hyperphosphatemia has been reported periodically in multiple myeloma (MM) patients with paraproteinemia. It is important for clinicians to recognize this phenomenon in order to avoid misdiagnosis and unnecessary treatment for true ...
Thakorn Pruktanakul, Rattana Leelawattana   +1 more
doaj   +1 more source

Protein and Phosphate Intakes are Associated with Hyperphosphatemia in Hemodialysis Patients at Sanglah Hospital, Bali, Indonesia

Majalah Kedokteran Bandung, 2022
Increased chronic kidney disease (CKD) mortality rate is significantly associated with increased blood phosphate levels. Hyperphosphatemia control is one of the main focuses in the management of hemodialysis (HD) patients.
Made Dyah Vismita Indramila Duarsa, Yenny Kandarini, Gede Wira Mahadita, Ni Nyoman Shinta Prasista Sari   +3 more
doaj   +1 more source

Association between phosphate disturbances and mortality among critically ill patients with sepsis or septic shock

BMC Pharmacology and Toxicology, 2021
Objective The aim of this study is to examine the association of hypophosphatemia and hyperphosphatemia on the first day of ICU admission with mortality in septic critically ill patients. Methods In this retrospective cohort study, all adult patients who
Shmeylan A. Al Harbi, Hasan M. Al-Dorzi, Albatool M. Al Meshari, Hani Tamim, Sheryl Ann I. Abdukahil, Musharaf Sadat, Yaseen Arabi   +6 more
doaj   +1 more source

Hyperphosphatemia and Outcomes in Critically Ill Patients: A Systematic Review and Meta-Analysis

Frontiers in Medicine, 2022
IntroductionSerum phosphate level is often deranged during critical illness. Hyperphosphatemia, as a marker of disease severity, attracts more and more attention.
Wen-He Zheng, Yan Yao, Hua Zhou, Yuan Xu, Hui-Bin Huang   +4 more
doaj   +1 more source

Association of Serum Phosphate Derangement With Mortality in Patients on Continuous Renal Replacement Therapy

Canadian Journal of Kidney Health and Disease, 2022
Background: There is limited evidence on the association of serum phosphate with mortality in patients receiving continuous renal replacement therapy (CRRT).
Charat Thongprayoon, Yeshwanter Radhakrishnan, Wisit Cheungpasitporn, Tananchai Petnak, Fawad Qureshi, Michael A. Mao, Kianoush B. Kashani   +6 more
doaj   +1 more source

Hyperphosphatemia and Cardiovascular Disease [PDF]

Frontiers in Cell and Developmental Biology, 2021
Hyperphosphatemia or even serum phosphate levels within the “normal laboratory range” are highly associated with increased cardiovascular disease risk and mortality in the general population and patients suffering from chronic kidney disease (CKD). As the kidney function declines, serum phosphate levels rise and subsequently induce the development of ...
Chao Zhou, Zhengyu Shi, Nan Ouyang, Xiongzhong Ruan, Xiongzhong Ruan   +4 more
openaire   +3 more sources